ישראל - עברית - Ministry of Health

vetmarket ltd, israel - milbemycin oxime; praziquantel - טבליות מצופות פילם - praziquantel 125 mg; milbemycin oxime 12.5 mg

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - febantel; praziquantel; pyrantel - טבליה - febantel 150 mg; pyrantel 50 mg; praziquantel 50 mg

ישראל - עברית - Ministry of Health

zoetis israel holding b.v., israel - febantel; praziquantel; pyrantel as embonate - טבליה - febantel 150 mg; pyrantel as embonate 50 mg; praziquantel 50 mg

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - infliximab - אבקה להכנת תמיסה מרוכזת לעירוי - infliximab 100 mg/vial - infliximab

ישראל - עברית - Ministry of Health

euromar ltd - milbemycin oxime; praziquantel - טבליה - praziquantel 125 mg; milbemycin oxime 12.5 mg

ישראל - עברית - Ministry of Health

euromar ltd - milbemycin oxime; praziquantel - praziquantel 40 mg; milbemycin oxime 16 mg

ישראל - עברית - Ministry of Health

euromar ltd - milbemycin oxime; praziquantel - טבליה - praziquantel 25 mg; milbemycin oxime 2.5 mg

ישראל - עברית - Ministry of Health

euromar ltd - milbemycin oxime; praziquantel - praziquantel 10 mg; milbemycin oxime 4 mg

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - protein l1 (type 11); protein l1 (type 16); protein l1 (type 18); protein l1 (type 6) - תרחיף להזרקה - protein l1 (type 18) 20 mcg / 0.5 ml; protein l1 (type 6) 20 mcg / 0.5 ml; protein l1 (type 11) 40 mcg / 0.5 ml; protein l1 (type 16) 40 mcg / 0.5 ml - combinations - combinations - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations..

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - neisseria meningitidis group a polysaccharide; neisseria meningitidis group c polysaccharide; neisseria meningitidis group w - 135 polysaccharide; neisseria meningitidis group y polysaccharide - אבקה וממס להכנת תמיסה להזרקה - neisseria meningitidis group y polysaccharide 5 mcg; neisseria meningitidis group w - 135 polysaccharide 5 mcg; neisseria meningitidis group c polysaccharide 5 mcg; neisseria meningitidis group a polysaccharide 5 mcg - other meningococcal monovalent purified polysaccharides antigen - other meningococcal monovalent purified polysaccharides antigen - nimenrix is indicated for active immunisation of individuals from the age of 12 months and above against invasive meningococcal diseases caused by neisseria meningitidis group a, c, w-135 and y.